Listen to audio brief:

On April 2, 2025, the White House announced new duties on low-value imports from the People’s Republic of China, set to take effect on May 2, 2025. This action is intended to address the increasing flow of synthetic opioids that are contributing to the ongoing crisis in the United States. The new regulations will end the previous duty-free status for certain shipments and will implement stricter tracking procedures to ensure compliance with U.S. laws.

Original: article